INDIPENDENT PROGNOSTIC VALUE OF SOLUBLE-SUPRESSION OF TUMORIGENICITY (s-ST2) IN PATIENTS AFFECTED BY PULMONARY HYPERTENSION
Anno:
2024
Introduction: According to ESC 2022 guidelines, pulmonary hypertension (PH) is a hemodynamic condition characterized by mean pulmonary arterial pressure>20 mmHg. Pulmonary arterial hypertension (PAH) represents 5% of the PH, with an unfavorable prognosis primarily because of late diagnosis and treatment. In PAH, it is important to evaluate the individual…